Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Resonance Specialties's Enterprise Value is ₹1,863.3 Mil.
Resonance Specialties's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil. Therefore, Resonance Specialties's EV-to-FCF for today is .
The historical rank and industry rank for Resonance Specialties's EV-to-FCF or its related term are showing as below:
BOM:524218'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 13.72
Current: 13.72
During the past 13 years, the highest EV-to-FCF of Resonance Specialties was 13.72. The lowest was 0.00. And the median was 0.00.
BOM:524218's EV-to-FCF is ranked better than 68.35% of 929
companies
in the Chemicals industry
Industry Median: 22.09
vs BOM:524218: 13.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Resonance Specialties's PE Ratio (TTM) for today is calculated as:
Resonance Specialties's share price for today is ₹178.10.
Resonance Specialties's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Resonance Specialties's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Specialties EV-to-FCF vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Resonance Specialties's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Resonance Specialties's EV-to-FCF falls into.
Resonance Specialties's current Enterprise Value is ₹1,863.3 Mil.
Resonance Specialties's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Resonance Specialties (BOM:524218) Overvalued in 2026?
Based on GuruFocus' analysis, Resonance Specialties stock appears to be overvalued.
The current stock price of ₹178.10 is trading 25.7% above its estimated GF Value™ of ₹141.64.
GuruFocus considers Resonance Specialties to be Modestly Overvalued.
Key valuation signals for BOM:524218:
EV-to-FCF:
GF Value™: ₹141.64 vs. price of ₹178.10 (25.7% above fair value)
No single metric tells the full story. See the BOM:524218 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Resonance Specialties Ltd is engaged in the manufacturing of chemicals. The company is manufacturing Pyridine, Picoline, Cynopyridine, and derivatives of the same. Bulk drugs and nutritional products are tolls converted. It delivers pyridine and related products. The company has only one segment which is Chemical Manufacturing. The company also manufactures anti-tuberculosis products such as Isoniazid. Geographically. It operates in India and Outside India. The majority of segment revenue is from Outside India.
70GF Score
Get the complete analysis for BOM:524218
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524218 has been successfully added to your 
